EUR 16,13
  • Tous les prix incluent la TVA.
En stock.
Expédié et vendu par Amazon.
Emballage cadeau disponible.
Quantité :1
Bad Pharma: How Drug Comp... a été ajouté à votre Panier
Amazon rachète votre
article EUR 3,02 en chèque-cadeau.
Vous l'avez déjà ?
Repliez vers l'arrière Repliez vers l'avant
Ecoutez Lecture en cours... Interrompu   Vous écoutez un extrait de l'édition audio Audible
En savoir plus
Voir les 2 images

Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients (Anglais) Broché – 1 avril 2014


Voir les formats et éditions Masquer les autres formats et éditions
Prix Amazon Neuf à partir de Occasion à partir de
Broché
"Veuillez réessayer"
EUR 16,13
EUR 10,07 EUR 12,45


Vendez cet article - Prix de rachat jusqu'à EUR 3,02
Vendez Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients contre un chèque-cadeau d'une valeur pouvant aller jusqu'à EUR 3,02, que vous pourrez ensuite utiliser sur tout le site Amazon.fr. Les valeurs de rachat peuvent varier (voir les critères d'éligibilité des produits). En savoir plus sur notre programme de reprise Amazon Rachète.

Détails sur le produit


Quels sont les autres articles que les clients achètent après avoir regardé cet article?

Commentaires en ligne

Il n'y a pas encore de commentaires clients sur Amazon.fr
5 étoiles
4 étoiles
3 étoiles
2 étoiles
1 étoiles

Commentaires client les plus utiles sur Amazon.com (beta)

Amazon.com: 8 commentaires
1 internautes sur 1 ont trouvé ce commentaire utile 
Dense but lucid examination of the problems with the pharmaceuticals industry 10 janvier 2015
Par Jules Jones - Publié sur Amazon.com
Format: Broché
Ben Goldacre is a very angry man, with good reason. In this book he lays out how the pharmaceutical industry has distorted drug research in pursuit of profit, sometimes intentionally, sometimes entirely without malice but with equally devastating effects for patient welfare. This matters because patients are prescribed less effective drugs, or drugs which are outright harmful, at huge financial expense to those paying for the drugs. This isn’t a conspiracy theory book; Goldacre is quite clear that many valuable drugs have come out of the industry, and that most of the people who work in it want to make better drugs. He sets out in detail how and why bias is introduced into both research and prescribing practices, putting it in layman’s terms but linking to the research papers and court documents that back up what he’s saying. He also addresses the failings of the current regulatory system, and proposes ways to improve things — pointing out that unless real controls with serious financial penalties are put in place, even those companies which genuinely want to reform will be under commercial pressure to continue with bad practice in a race to the bottom.

It’s a dense and at times exhausting read. But Goldacre has done a decent job of making the issue accessible to a wide audience with a direct interest, from patients to practising doctors and academics. You can skim a lot of the book to get the general gist, or you can read it in details without following the links, or you can dig into research material he drew on and has laid out in meticulous footnotes and citations. He concludes the original edition with practical suggestions about what individual people can do to improve things, often simply by asking questions.

I read the second edition, which has a “what happened next” chapter about the reaction to the first edition. As he had predicted, there was a backlash in an attempt to discredit him — but there was also a lot of covert feedback from industry personnel acknowledging the problems and considering how to improve things. While there’s always a “the lurkers support me in email” issue with uncredited sources, he does also offer some examples of companies which have publicly moved to improve transparency.

Bad Pharma is an angry but rational examination of a real problem that affects millions of people, including almost anyone reading this review. It’s a worthwhile read, even if it makes for uncomfortable reading for patients, doctors and companies alike.
An Important Call to Action 22 janvier 2015
Par Barbara N. Kuehner - Publié sur Amazon.com
Format: Broché Achat vérifié
Ben Goldacre is right on target, and I hope his efforts will result in similar examinations of medical devices, treatments (especially wound care), monitoring systems (e.g. blood glucose), and therapeutic products requiring a prescription. As a U.S. based nurse who has "benefitted" from free lunches, conferences, promotional products and educational materials, I know first hand how insidiously marketing efforts penetrate practice settings and educational institutions. In the U.S., I wonder about marketing efforts directed toward insurance companies, where drug and treatment decisions are increasingly being made. The "Afterward" hints at some progress, but the pervasiveness of the problem as laid out so thoroughly in the book illustrates the multiple challenges. Thank you, Dr. Goldacre, for providing in one volume both a documented description and several action plans that should that should stimulate a few of us to step up and speak out. I highly recommend this book to those who care about excellence in health care and the integrity of the scientific method.
Excellent Information and Actionable Steps 25 janvier 2015
Par Bill Cory - Publié sur Amazon.com
Format: Broché Achat vérifié
An update to Goldacre's first edition, this one adds helpful information on all of the problems with the pharmaceutical industry, government regulators, medical professionals and media under-reporting of drug problems. It is an excellent partner to his "Bad Science." Written in an easy-to-read, casual style, its pages turn more swiftly that one would expect.

The author has added steps that can be taken to begin to correct the problem of missing data and erroneous reporting of trial results, divided into steps for medical personnel, patients, regulators, etc.
2 internautes sur 3 ont trouvé ce commentaire utile 
This is a great resource for literature regarding these issues 1 août 2014
Par Michael Shen - Publié sur Amazon.com
Format: Broché Achat vérifié
This is a great resource for literature regarding these issues. It makes it easy because Ben has done all the research for you! Of course, if you truly advocate evidence-based medicine, don't be afraid to appraise the literature yourself.
2 internautes sur 3 ont trouvé ce commentaire utile 
Great information to know 1 août 2014
Par Robert L. Hall Jr. - Publié sur Amazon.com
Format: Broché Achat vérifié
The corruption in big pharma and politics runs deeper than can imagine. Read this and you will be informed, and never think the same again. Good read!
Ces commentaires ont-ils été utiles ? Dites-le-nous


Commentaires

Souhaitez-vous compléter ou améliorer les informations sur ce produit ? Ou faire modifier les images?